1. Home
  2. Companies
  3. EIQ
  4. Material Events

EchoIQ (ASX:EIQ) — Material Events

ASX:EIQ · 15 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Major 5 articles Significant 8 articles Notable 2 articles Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
8
Echo IQ maps three FDA routes after EchoSolv HF setbackHigh
Echo IQ outlines pathways to pursue FDA clearance for EchoSolv HF after NSE determination
17 Sept 2026 ·Regulatory Update ·Unexpected ·86
Echo IQ Advances US Market Bid with FDA Submission for Heart Failure AI ToolMedium
Echo IQ lodges FDA 510(k) submission for EchoSolv HF, targeting $60B US heart failure market
15 Dec 2025 ·Regulatory Submission ·85
Echo IQ Expands Mayo Clinic Deal Ahead of FDA Nod for EchoSolv HFHigh
Echo IQ expands Mayo Clinic agreement for EchoSolv HF distribution pending FDA clearance
24 Mar 2026 ·Commercial Agreement Update ·85
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.